Consequences of Using Non-Frozen Delivery Systems Putting Biopharmaceutical Cargo at Risk

May 09, 2016

Non-frozen delivery systems for new drug therapies do not always provide acceptable temperature control. In the event of a transportation delay, medicines that require strict temperature management can be compromised. For these reasons, current packing configurations are being reevaluated in terms of the risks they pose to product integrity.

In this informative article published in Industry Today, Mark Sawicki, Ph.D., Cryoport chief commercial officer, describes how regulatory groups, such as ISO, are reviewing guidelines for the storage and distribution of regenerative therapies and other critical shipments. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, Frozen Biological Shipping